PMDA inspection
GlaxoSmithKline Biologicals S.A. Wavre
PMDA inspection 5130508031209 · Belgium · Suitable
Key facts
| Control number | 5130508031209 |
|---|---|
| Manufacturing site | GlaxoSmithKline Biologicals S.A. Wavre |
| Location | Parc de la Noire Epine Rue Fleming 20 1300 Wavre, Belgium |
| Country | Belgium |
| Product type | Pharmaceuticals |
| Application type | Complete Change |
| Inspection method | Remote |
| Inspection month | Mar 1, 2024 |
| Result | Suitable |
| Result notified | Mar 4, 2024 |
| PMDA registration | AG20800024 |
About PMDA GMP inspections (Japan)
Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan